Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Total Debt: 2014-2025

Historic Total Debt for Surgery Partners (SGRY) over the last 12 years, with Q3 2025 value amounting to $3.6 billion.

  • Surgery Partners' Total Debt rose 1165.91% to $3.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 billion, marking a year-over-year increase of 1165.91%. This contributed to the annual value of $3.4 billion for FY2024, which is 2144.79% up from last year.
  • Latest data reveals that Surgery Partners reported Total Debt of $3.6 billion as of Q3 2025, which was up 1165.91% from $3.6 billion recorded in Q2 2025.
  • Over the past 5 years, Surgery Partners' Total Debt peaked at $3.6 billion during Q2 2025, and registered a low of $2.6 billion during Q2 2023.
  • Over the past 5 years, Surgery Partners' median Total Debt value was $2.9 billion (recorded in 2021), while the average stood at $3.0 billion.
  • Its Total Debt has fluctuated over the past 5 years, first plummeted by 1678.27% in 2023, then surged by 2367.82% in 2025.
  • Surgery Partners' Total Debt (Quarter) stood at $2.9 billion in 2021, then decreased by 10.79% to $2.6 billion in 2022, then increased by 5.85% to $2.8 billion in 2023, then grew by 21.45% to $3.4 billion in 2024, then rose by 5.74% to $3.6 billion in 2025.
  • Its Total Debt stands at $3.6 billion for Q3 2025, versus $3.6 billion for Q2 2025 and $3.6 billion for Q1 2025.